Galectin Therapeutics Inc (GALT)

Jul 23, 2025

Galectin Therapeutics Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What drives Galectin Therapeutics Inc. stock priceRapidly growing investment returns - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

What analysts say about Galectin Therapeutics Inc. stockAccelerated wealth building - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Galectin Therapeutics Inc. a good long term investmentAccelerated wealth building - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200 Day Moving AverageHere's Why - MarketBeat

Jul 22, 2025

Jul 18, 2025

Director’s Bold Move: Major Stock Purchase at Galectin Therapeutics! - TipRanks

Jul 18, 2025

Jul 18, 2025

Freeman buys Galectin therapeutics (GALT) stock worth $14,495 - Investing.com Australia

Jul 18, 2025

Jul 18, 2025

Freeman buys Galectin therapeutics (GALT) stock worth $14,495 By Investing.com - Investing.com Nigeria

Jul 18, 2025

Jul 15, 2025

What makes Galectin Therapeutics Inc. stock price move sharplyMarket Ready Callouts - Newser

Jul 15, 2025

Jul 15, 2025

Why Galectin Therapeutics Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser

Jul 15, 2025

Jul 15, 2025

Why Did Galectin Therapeutics (GALT) Soar 14.04%? - AInvest

Jul 15, 2025

Jul 15, 2025

How Galectin Therapeutics Inc. stock performs during market volatilityFree Discussion Group - Newser

Jul 15, 2025

Jul 13, 2025

Galectin Therapeutics (NASDAQ:GALT) Share Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Jul 13, 2025

Jul 10, 2025

Galectin Therapeutics announces new $10 million credit line from Richard Uihlein - MSN

Jul 10, 2025

Jul 10, 2025

Galectin Therapeutics Secures $10M Credit Line for Growth - The Globe and Mail

Jul 10, 2025

Jul 10, 2025

Galectin Therapeutics secures $10 million credit line from board chairman By Investing.com - Investing.com South Africa

Jul 10, 2025

Jul 09, 2025

Galectin Therapeutics secures $10 million credit line from board chairman - Investing.com Australia

Jul 09, 2025

Jul 09, 2025

Galectin Therapeutics Inc. announced that it expects to receive $10 million in funding - MarketScreener

Jul 09, 2025

Jul 09, 2025

Galectin Therapeutics Secures Additional $10 million Credit Line - MarketScreener

Jul 09, 2025

Jul 09, 2025

ALVO 6-K: Alvotech discloses Ivers-Lee Group acquisition | GALT SEC FilingForm 8-K - Stock Titan

Jul 09, 2025

Jul 09, 2025

Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026 - TradingView

Jul 09, 2025

Jul 09, 2025

Board Chairman Injects $10M Into Galectin's MASH Treatment Program: Extended Funding Through 2026 - Stock Titan

Jul 09, 2025

Jul 04, 2025

Galectin Therapeutics (NASDAQ:GALT) Share Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat

Jul 04, 2025

Jul 01, 2025

Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock price dropped 13% last week; individual investors would not be happy - simplywall.st

Jul 01, 2025

Jun 24, 2025

Galectin Therapeutics (NASDAQ:GALT) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Jun 24, 2025

Jun 22, 2025

What is HC Wainwright's Estimate for GALT Q2 Earnings? - MarketBeat

Jun 22, 2025

Jun 20, 2025

HC Wainwright Begins Coverage on Galectin Therapeutics (NASDAQ:GALT) - MarketBeat

Jun 20, 2025

Jun 19, 2025

Galectin Therapeutics Inc. (NASDAQ:GALT) Stock Holdings Lifted by Wealth Enhancement Advisory Services LLC - Defense World

Jun 19, 2025

Jun 18, 2025

Galectin Therapeutics (NASDAQ:GALT) Now Covered by Analysts at HC Wainwright - Defense World

Jun 18, 2025

Jun 18, 2025

Galectin Therapeutics Soars 22% Amid Technical Puzzles and Retail Surge - AInvest

Jun 18, 2025

Jun 17, 2025

Galectin Therapeutics stock rating initiated at buy by H.C. Wainwright - Investing.com Nigeria

Jun 17, 2025

Jun 17, 2025

Analyst Forecast For Galectin Therapeutics Inc (NASDAQ: GALT) - Stocksregister

Jun 17, 2025

Jun 17, 2025

Galectin Therapeutics (GALT) Receives Buy Rating from H.C. Wainw - GuruFocus

Jun 17, 2025

Jun 17, 2025

HC Wainwright & Co. Initiates Coverage with Buy Rating on GALT | - GuruFocus

Jun 17, 2025

Jun 17, 2025

Galectin Therapeutics (GALT) Receives Buy Rating from H.C. Wainwright | GALT Stock News - GuruFocus

Jun 17, 2025